% alzhub.org topic: immunoassay % Source: https://alzhub.org/topic/immunoassay % 7 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{wojdala2025-39747866, author = {Wojdała, A. L. and Bellomo, G. and Gaetani, L. and Teunissen, C. E. and Parnetti, L. and Chiasserini, D.}, title = {{Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer's disease biomarkers}}, journal = {Nature communications}, year = {2025}, doi = {10.1038/s41467-024-54878-8}, pmid = {39747866}, url = {https://doi.org/10.1038/s41467-024-54878-8} } @article{lehmann2024-38658136, author = {Lehmann, S. and Schraen-Maschke, S. and Vidal, J. S. and Delaby, C. and Buee, L. and Blanc, F. and Paquet, C. and Allinquant, B. and others}, title = {{Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment}}, journal = {Journal of neurology, neurosurgery, and psychiatry}, year = {2024}, doi = {10.1136/jnnp-2024-333467}, pmid = {38658136}, url = {https://doi.org/10.1136/jnnp-2024-333467} } @article{agnello2024-38992063, author = {Agnello, L. and Giglio, R. V. and Del Ben, F. and Piccoli, T. and Colletti, T. and Scazzone, C. and Lo Sasso, B. and Ciaccio, A. M. and others}, title = {{Evaluation of core Biomarkers of Alzheimer's disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform}}, journal = {Scientific reports}, year = {2024}, doi = {10.1038/s41598-024-66923-z}, pmid = {38992063}, url = {https://doi.org/10.1038/s41598-024-66923-z} } @article{kivisakk2024-38182740, author = {Kivisäkk, P. and Fatima, H. A. and Cahoon, D. S. and Otieno, B. and Chacko, L. and Minooei, F. and Demos, C. and Stengelin, M. and others}, title = {{Clinical evaluation of a novel plasma pTau217 electrochemiluminescence immunoassay in Alzheimer's disease}}, journal = {Scientific reports}, year = {2024}, doi = {10.1038/s41598-024-51334-x}, pmid = {38182740}, url = {https://doi.org/10.1038/s41598-024-51334-x} } @article{yamashita2022-35739591, author = {Yamashita, K. and Miura, M. and Watanabe, S. and Ishiki, K. and Arimatsu, Y. and Kawahira, J. and Kubo, T. and Sasaki, K. and others}, title = {{Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy}}, journal = {Alzheimer's research \& therapy}, year = {2022}, doi = {10.1186/s13195-022-01029-0}, pmid = {35739591}, url = {https://doi.org/10.1186/s13195-022-01029-0} } @article{keshavan2021-33598527, author = {Keshavan, A. and Wellington, H. and Chen, Z. and Khatun, A. and Chapman, M. and Hart, M. and Cash, D. M. and Coath, W. and others}, title = {{Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays}}, journal = {Alzheimer's \& dementia (Amsterdam, Netherlands)}, year = {2021}, doi = {10.1002/dad2.12131}, pmid = {33598527}, url = {https://doi.org/10.1002/dad2.12131} } @article{shahpasandkroner2018-30526652, author = {Shahpasand-Kroner, H. and Klafki, H. W. and Bauer, C. and Schuchhardt, J. and Hüttenrauch, M. and Stazi, M. and Bouter, C. and Wirths, O. and others}, title = {{A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2018}, doi = {10.1186/s13195-018-0448-x}, pmid = {30526652}, url = {https://doi.org/10.1186/s13195-018-0448-x} }